Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tadalafil for ED and BPH (COMORBID)
NCT00855582Phase 3Completed
- Sponsor
- Eli Lilly and Company
- Start
- Mar 2009
- Primary completion
- Jul 2010
- Modality
- Small Molecules
- Countries
- 9
01
Overview
A Phase 3 trial of tadalafil in erectile dysfunction (ED), benign prostatic hyperplasia (BPH), sponsored by Eli Lilly and Company. Started Mar 2009; status: completed.
02
Drugs
tadalafil
03
Conditions
erectile dysfunction (ED)benign prostatic hyperplasia (BPH)
Beyond the preview
Go deeper on NCT00855582.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00855582.